Fingerprint

Dive into the research topics of 'Phase III trial comparing 3-6months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: Safety and compliance in the TOSCA trial'. Together they form a unique fingerprint.

Medicine & Life Sciences